In work that sheds light on both the toxicity of amyloid beta and the role that immune system molecules play in the brain, researchers have shown that amyloid beta oligomers can weaken synapses by binding to the PirB receptor. In animal models of Alzheimer’s disease, such weakening went along with cognitive problems.